Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

Renub Researchwww.renub.com

Published: December, 2012Copyright © 2012 Renub Research – All Rights Reserved

© Renub Research Page 2 of 18

Pediatric Vaccines Market Analysis

Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has

doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market

is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during

2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7,

Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.

It is predicted that Pediatric proprietary vaccines will lead the segment with little less than

60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines

market are expected to show stagnant growth in future due to lower margins and the mature

nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines

control 55% of the market share in 2011.

In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown

decline continuously from the year 2001 till 2011. Polio remains endemic merely in three

countries and the good news is that India has not reported a single case from the past two

years and on the verge of being called a polio free country.

DTP are the most utilized vaccines in the pediatric vaccines market which contributed less

than 10,000 Million doses in 2011. Pediatric Hepatitis and Polio vaccines are also mostly used

vaccines which consumed more than 6,000 Million doses in 2011. In case of Rotavirus vaccine

although the price of Rotavirus vaccine has declined but still its present prices are expensive

than other pediatric vaccines. However despite all the impediments pediatric vaccines

industry is expected to remain highly active in the future, fueled by the encouragement and

financing from governments and other health organizations.

Renub Research report titled "Pediatric Vaccines Market, Doses, Immunization, Cases and

Forecast: Worldwide Analysis” talks about the pediatric vaccines. The report provides

information on all the Nine (9) Pediatric Vaccines Market, Doses, Immunization and Number of

Cases by region in the world. This report covers in detail all aspects of past, present and

future scenario. This report provides market landscape and market share information of the

Pediatric Combinations & Booster, Pediatric Enhanced Combination and Pediatric Proprietary

© Renub Research Page 3 of 18

Vaccines Market. The report also entails major factors driving the pediatric vaccine market

and challenges of pediatric vaccine market.

Pediatric Vaccines Covered in this Report are as follows:

Measles, Mumps & Rubella (MMR) Vaccines, Haemophilus Influenzae Type B (HIB) Vaccines,

Polio Vaccines, Diphtheria, Tetanus & Pertussis (Combos) Vaccines, Pneumococcal Vaccines

Rotavirus Vaccines, Hepatitis Pediatric Vaccines, Varicella/Chicken Pox Vaccines and Other

Pediatric Vaccines

All the Pediatric Vaccines in this Report have been Studied from Four View Points:

Number of Cases Reported for all 9 Pediatric Diseases by Region from 2001 to 2011

Number of Doses Reported and Forecast for all 9 Pediatric Vaccine from 2005 to 2015

Immunization Coverage for all 9 Pediatric Vaccines and Forecast from 2005 to 2015

Market Size for all 9 Pediatric Vaccines and Forecast from 2005 to 2015

Key Topics Covered in the Report

Worldwide – Pediatric Vaccines Market and Forecast (2006 - 2015)

Worldwide – Pediatric Vaccines Market Share and Forecast (Sector wise) (2005 - 2015)

Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 - 2015)

By Sector (All 9) – Pediatric Vaccines Market and Forecast (2005 - 2015)

By Region - Pediatric Disease Cases (2001 – 2011)

Pediatric Vaccines Doses and Forecast (2005 – 2015)

Pediatric Vaccines Immunization Coverage and Forecast (2005 - 2015)

All 9 Pediatric Vaccines Market and Forecast (2005 - 2015)

Growth Drivers of Pediatric Vaccines Market

Challenges of Pediatric Vaccines Market

© Renub Research Page 4 of 18

Data Sources

This report is built using data and information sourced from proprietary databases, primary

and secondary research and in-house analysis by Renub Research team of industry experts.

Primary sources include industry surveys and telephone interviews with industry experts.

Secondary sources information and data has been collected from various printable and non-

printable sources like search engines, News websites, Government Websites, Trade Journals,

White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books,

Industry Portals, Industry Associations and access to more than 100 paid databases.

© Renub Research Page 5 of 18

About Us

RReennuubb RReesseeaarrcchh is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in

international Business-to-Business Researches, Surveys, Business and Consulting. Throughout

the years we have acquired expertise in most market sectors, including Information

Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services

(Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG,

Consumer Goods, Logistics, Governmental, Social, and Others.

Our core team is comprised of an experienced people holding graduate, post graduate and

Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information

Technology, Environmental Science and many more. Our research help make the business

decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We

support many blue chip companies by providing them findings and perspectives across a wide

range of markets. Our research reports offer a blend of information insight, analysis and

forecasting that is essential in today’s ultra-competitive markets.

For more information on us or to view any of our sample work you can

mail us at info@renub.com

© Renub Research Page 6 of 18

Published

By

RReennuubb RReesseeaarrcchh

A–116B, Sector–27

Noida – 201301

Phone: +91-120-421-9822, 254-5750 (India)

+1-678-302-0700 (USA)

Fax : +91-120-424-9780

Email: info@renub.com

www.renub.com

© Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

Renub Research, 2012

Edition 1.0

All rights reserved. This publication is protected

by copyright. No part of it may be reproduced, stored

in a retrieval system or transmitted, in any form or by

any means, electronic mechanical, photocopying,

recording or otherwise without the prior written

permission of the publishers

© Renub Research Page 7 of 18

Table of Contents

1. Executive Summary

2. Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015)

3. Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015)

4. Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015)

5. By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015)

5.1 Worldwide – Pediatric Combinations & Boosters Vaccines Market

5.2 Worldwide – Pediatric Enhanced Combinations Vaccines Market

5.3 Worldwide – Pediatric Proprietary Vaccines Market

6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast

6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015)

6.1.1 Number of Measles, Mumps & Rubella Cases (2001 – 2011)

6.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses

6.1.3 Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines

6.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines

6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015)

6.2.1 Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011)

6.2.2 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses

6.2.3 Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines

6.2.4 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines

6.3 Polio Vaccines and Forecast (2005 – 2015)

6.3.1 Number of Polio Cases (2001 – 2011)

6.3.2 Number of Polio Vaccines Doses

6.3.3 Immunization Coverage of Polio Vaccines

6.3.4 Market Size of Polio Vaccines

6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015)

6.4.1 Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011)

6.4.2 Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses

6.4.3 Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines

6.4.4 Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines

6.5 Pneumococcal Vaccines and Forecast (2005 – 2015)

© Renub Research Page 8 of 18

6.5.1 Number of Pneumococcal Cases (2000)

6.5.2 Number of Pneumococcal Vaccines Doses

6.5.3 Immunization Coverage of Pneumococcal Vaccines

6.5.4 Market Size of Pneumococcal Vaccines

6.6 Rotavirus Vaccine and Forecast (2006 – 2015)

6.6.1 Number of Rotavirus Cases (2008 & 2009)

6.6.2 Number of Rotavirus Vaccines Doses

6.6.3 Immunization Coverage of Rotavirus Vaccines

6.6.4 Market Size of Rotavirus Vaccine

6.7 Hepatitis Pediatric Vaccines and Forecast (2005 – 2015)

6.7.1 Number of Hepatitis Pediatric Vaccines Doses

6.7.2 Immunization Coverage of Hepatitis Pediatric Vaccines

6.7.3 Market Size of Hepatitis Pediatric Vaccines

6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015)

6.8.1 Number of Varicella/Chicken Pox Vaccines Doses

6.8.2 Market Size of Varicella/Chicken Pox Vaccines

6.9 Other Pediatric Vaccines and Forecast (2005 – 2015)

6.9.1 Market Size of Other Pediatric Vaccines

7. Growth Drivers of Pediatric Vaccines Market

7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be

Done Error! Bookmark not defined.

7.1.1 Rotavirus Vaccine Introduction

7.1.2 Financial Challenges

7.1.3 Cost Effective

7.1.4 Future Steps

7.1.5 Conclusion

7.2 GAVI Model Increases Vaccine Manufacturers

7.2.1 The Partnership Model

7.2.2 The Business Model

7.3 WHO Global Vaccine Action Plan (2011 - 2020)

8. Challenges of Pediatric Vaccine Market

8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines

8.2 Impediment in Pediatric Vaccine Research & Development

© Renub Research Page 9 of 18

8.3 Barriers to New Entrants in the Pediatric Vaccines Market

© Renub Research Page 10 of 18

List of Figures

Figure 2-1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011

Figure 2-2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015

Figure 3-1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011

Figure 3-2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 –

2015

Figure 5-1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011

Figure 5-2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$),

2012 – 2015

Figure 5-3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011

Figure 5-4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$),

2012 – 2015

Figure 5-5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011

Figure 5-6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015

Figure 6-1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011

Figure 6-2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015

Figure 6-3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011

Figure 6-4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses),

2012 – 2015

Figure 6-5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011

Figure 6-6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 –

2015

Figure 6-7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income

Countries, 1980 – 2010

Figure 6-8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses),

2005 – 2011

Figure 6-9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines

(Million Doses), 2012 – 2015

Figure 6-10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million

Doses), 2005 – 2011

Figure 6-11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type B

Vaccines (Million Doses), 2012 – 2015

Figure 6-12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 –

2011

Figure 6-13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million

US$), 2012 – 2015

© Renub Research Page 11 of 18

Figure 6-14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011

Figure 6-15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015

Figure 6-16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011

Figure 6-17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 –

2015

Figure 6-18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011

Figure 6-19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015

Figure 6-20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011

Figure 6-21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015

Figure 6-22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011

Figure 6-23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 –

2015

Figure 6-24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005

– 2011

Figure 6-25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market

(Million US$), 2012 – 2015

Figure 6-26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025

Figure 6-27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011

Figure 6-28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012

– 2015

Figure 6-29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 –

2011

Figure 6-30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (Million

Doses), 2012 – 2015

Figure 6-31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011

Figure 6-32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015

Figure 6-33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011

Figure 6-34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 –

2015

Figure 6-35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011

Figure 6-36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses),

2012 – 2015

Figure 6-37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011

Figure 6-38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015

Figure 6-39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011

Figure 6-40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses),

2012 – 2015

© Renub Research Page 12 of 18

Figure 6-41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 –

2011

Figure 6-42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million

Doses), 2012 – 2015

Figure 6-43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010

Figure 6-44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011

Figure 6-45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015

Figure 6-46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011

Figure 6-47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 –

2015

Figure 6-48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011

Figure 6-49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015

Figure 6-50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011

Figure 6-51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$), 2012 – 2015

Figure 7-1: Prices of Childhood Vaccines (US$), 2011

Figure 7-2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012

Figure 7-3: Increasing Number of GAVI Suppliers Based in Emerging Markets

© Renub Research Page 13 of 18

List of Tables

Table 4-1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011

Table 4-2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 –

2015

Table 6-1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011

Table 6-2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011

Table 6-3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011

Table 6-4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B Meningitis

Cases (Number), 2001 – 2011

Table 6-5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011

Table 6-6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011

Table 6-7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011

Table 6-8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011

Table 6-9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011

Table 6-10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5

Years of Age (Number), 2000

Table 6-11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number),

2008 – 2009

Table 6-12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance Positive

Cases (Number & Percent), 2009

Table 7-1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020

Table 7-2: Goal-Level Indicators, 2015 & 2020

© Renub Research Page 14 of 18

Related Reports

Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable

Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device)

Market Forecast, Clinical Trials, M&A

Western Europe (EU-16) In Vitro Diagnostics Market Report & Forecast (2012 – 2015)

Asia Medical Tourism Analysis and Forecast to 2015

Clinical Chemistry Market Report & Forecast (2012 – 2015): Global Analysis

Hepatitis C (HCV) Market Forecast & Drugs Pipeline Analysis to 2016

Influenza Vaccine Market Opportunities and Challenges: Worldwide Forecast

Genetic Testing Market and Forecast - Global Analysis 2010 – 2015

USA Cardiovascular Devices Market Trends and Forecast (2010 – 2015)

Global Osteoporosis Market & Drugs Analysis 2010 – 2015

Global Schizophrenia Prevalence, Companies Analysis & Drugs Forecast (2010 – 2015)

Molecular Diagnostics Market & Forecast (By Application, Technology, Countries, Companies &

Clinical Trials) to 2017: Global Analysis

Alzheimer’s Disease Patients & Market Worldwide, Future Scenario (2010 – 2015) & Drugs

Analysis

Personalized Medicine Market (2010 - 2015) - By Segments, Technologies, Opportunities,

Challenges & Future Forecast

© Renub Research Page 15 of 18

Our Partial List of Clients

Bain

WAKE Technology Services, Inc.

PSS World Medical

Relypsa

C&K components

Konkuk University

Resonetics

Samsung

SEKISUI MEDICAL CO. LTD.

Plentyoffish Media INC

Arthur D Little Gmbh

Morgan Stanley

Takeda Pharmaceutical Corporation

Hokkai School of Commerce

Ministry of Manpower Singapore

GenOmind, LLC.

Goldman Sachs & Co

NTT Advanced Technology

Tokyo Womens Medical University

The Chemo-Sero-Therapeutic Research

Trade Council of Iceland

Jpmorgan, Ets Trading

GE Healthcare IT

ixia communications

Redbus

Becton Dickinson

Pfizer

Intercell

Sanofi Pasteur

Stanford Burgess

Pequot Capital

DMI

Transgene S.A.

ixia communications

Toyota Tsusho Amercia Inc.

National Health Research Institutes

Abbott Diabetes Care

Corning Incorporated - Life Sciences

L.E.K. Consulting GmbH

Syntiron

MediVas LLC

Credit Suisse

Dune Medical

QIAGEN

Inje University

Mapp Biopharmaceutical

Institute for Information Industry

NorDiag ASA

Rep e Inv Medicas SA de

Innogenetics

© Renub Research Page 16 of 18

Order Form

Scan and e-mail this page to info@renub.com, alternatively one can also write the Contact

Information in an e-mail and mail it. Else you can also fax this form to +91-120-424-9780

Questions? Please call +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

info@renub.com

Format

Report Title: Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide

Analysis

Single User (Email from Publisher)

Hard Copy (Mail Delivery)

CD – Rom (Mail Delivery)

Global Site License (Multiple User License)

US$ 1,400 US$ 1,550 US$ 1,500 US$ 2,200

For ordering this report: Three easy ways to place your order:

1) Order online by Credit Card (Visa, MasterCard, etc.):

http://www.renub.com/report/pediatric-vaccines-market-doses-immunization-cases-and-

forecast-worldwide-analysis-86

2) Order by Wire Transfer:

http://www.renub.com/report/wiretransfer.aspx?id=86&pid=1325

To pay by Wire Transfer, please, fill in your contact details in the form below:

© Renub Research Page 17 of 18

Bank Details

Account Name: Renub Research

A/C No.: 109102000023296

Name of Bank: IDBI Bank Ltd.

Swift Code: IBKLINBB010

Bank Address: 4th Floor

Indian Red Cross Building

1 Red Cross Road

Opposite Parliament Street

New Delhi – 110001

India

Contact Information

First Name: Last Name:

Email:

Job Title:

Company:

Address:

City:

Postal/Zip Code:

Country:

Phone:

Mobile:

Fax:

Report Format:

Your message:

© Renub Research Page 18 of 18

3) Order by Check

Please post the check accompanied by this form, to:

Company Address: Renub Research

A -116B

Sector -27

Noida - 201301

Uttar Pradesh

India

Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at

info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us

Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090

LinkedIn: http://www.linkedin.com/company/renub-research

Twitter: http://twitter.com/RenubResearch